Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Revenue (Gross)
Ratios

Serina Therapeutics (SER) Long-Term Debt Issuances (2023)

Serina Therapeutics (SER) has disclosed Long-Term Debt Issuances for 1 consecutive years, with $10.1 million as the latest value for Q1 2023.

  • Quarterly Long-Term Debt Issuances changed N/A to $10.1 million in Q1 2023 from the year-ago period, while the trailing twelve-month figure was $10.1 million through Dec 2023, changed N/A year-over-year, with the annual reading at $4.9 million for FY2025, N/A changed from the prior year.
  • Long-Term Debt Issuances hit $10.1 million in Q1 2023 for Serina Therapeutics.
  • In the past five years, Long-Term Debt Issuances ranged from a high of $10.1 million in Q1 2023 to a low of $10.1 million in Q1 2023.